January 2023 in “Journal of Cosmetic Dermatology” This case series reports on three school-aged children developing alopecia areata shortly after COVID-19 infection, suggesting a potential association between the virus and this autoimmune hair loss condition.
1 citations
,
November 2022 in “Anais Brasileiros de Dermatologia” This study found that hospitalized pediatric COVID-19 patients frequently display skin, mucosal, and nail manifestations, particularly periorbital erythema and edema, and the authors suggest COVID-19 be considered among childhood viral exanthem rashes.
8 citations
,
May 2022 in “Journal of medicine and life” This study found that telogen effluvium, a type of hair loss, was prevalent among 24% of COVID-19 patients, likely triggered by stress and medication related to the illness.
7 citations
,
March 2022 in “Indian Pediatrics” This review summarizes the various skin manifestations of SARS-CoV-2 infection in children, noting that chilblains are the most common and that many affected children are asymptomatic.
11 citations
,
May 2021 in “Journal of The American Academy of Dermatology” This study found that mild-to-moderate COVID-19 was not associated with worsening in patients with pre-existing alopecia areata.
2 citations
,
February 2021 in “The Pediatric Infectious Disease Journal” This case study describes hair loss as a potential late complication of multisystem inflammatory syndrome in children, observed in a 7-year-old girl who developed Telogen effluvium 73 days post-diagnosis.
11 citations
,
December 2020 in “Journal of Drugs in Dermatology” This study reported that COVID-19 skin manifestations, such as exanthema and chilblains, varied in timing but resolved positively with proper treatment.
80 citations
,
June 2020 in “Dermatopathology” This review discusses the various skin lesions associated with COVID-19, which vary in type and severity, and reports that these lesions can appear before other symptoms and typically resolve spontaneously.